111 related articles for article (PubMed ID: 16455483)
1. Toxic epidermal necrolysis in patient with breast cancer receiving letrozole.
Chia WK; Lim YL; Greaves MW; Ang P
Lancet Oncol; 2006 Feb; 7(2):184-5. PubMed ID: 16455483
[No Abstract] [Full Text] [Related]
2. Letrozole withdrawal response in locally advanced breast cancer.
Lambertini M; Pronzato P; Giraudi S; Levaggi A; Bighin C; Del Mastro L
Ann Oncol; 2011 Aug; 22(8):1927-8. PubMed ID: 21562073
[No Abstract] [Full Text] [Related]
3. Radiation recall reaction with letrozole therapy in breast cancer.
Foster LM; Mahoney ME; Harmon MW; Allen JW; Luh JY
Clin Breast Cancer; 2014 Jun; 14(3):e95-7. PubMed ID: 24512859
[No Abstract] [Full Text] [Related]
4. Reversible pancytopenia caused by oral letrozole assumption in a patient with recurrent breast cancer.
Sperone P; Gorzegno G; Berruti A; Familiari U; Dogliotti L
J Clin Oncol; 2002 Sep; 20(17):3747-8. PubMed ID: 12202678
[No Abstract] [Full Text] [Related]
5. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
[TBL] [Abstract][Full Text] [Related]
6. A rare case of breast cancer metastasis.
Kykalos S; Mantas D; Dimitroulis D; Alexandrou P; Kostakis A
Breast Dis; 2010; 31(1):53-5. PubMed ID: 20644251
[No Abstract] [Full Text] [Related]
7. Anal localization as first manifestation of metastatic ductal breast carcinoma.
Haberstich R; Tuech JJ; Wilt M; Rodier JF
Tech Coloproctol; 2005 Dec; 9(3):237-8. PubMed ID: 16328121
[TBL] [Abstract][Full Text] [Related]
8. Huge response to letrozole in inoperable T4 breast cancer: a case report.
Di Cosimo S; Altomare V; Ferretti G; Gravante G; Rabitti C; Rea F; Arullani A; D'Aprile M
Clin Ter; 2001; 152(4):263-5. PubMed ID: 11725620
[TBL] [Abstract][Full Text] [Related]
9. Toxic epidermal necrolysis as a complication of treatment with voriconazole.
Huang DB; Wu JJ; Lahart CJ
South Med J; 2004 Nov; 97(11):1116-7. PubMed ID: 15586606
[TBL] [Abstract][Full Text] [Related]
10. Phase II parallel group study showing comparable efficacy between premenopausal metastatic breast cancer patients treated with letrozole plus goserelin and postmenopausal patients treated with letrozole alone as first-line hormone therapy.
Park IH; Ro J; Lee KS; Kim EA; Kwon Y; Nam BH; Jung SY; Lee S; Kim SW; Kang HS
J Clin Oncol; 2010 Jun; 28(16):2705-11. PubMed ID: 20421538
[TBL] [Abstract][Full Text] [Related]
11. Posterior reversible encephalopathy syndrome: more than meets the eye.
Munoz J; Kumar VA; Hamilton J; Pasche LJ; Langford LA; Taggart MW; Kamiya-Matsuoka C; Tummala S; Moulder S; Kurzrock R
J Clin Oncol; 2013 Jul; 31(20):e360-3. PubMed ID: 23733774
[No Abstract] [Full Text] [Related]
12. Base of the tongue metastasis: aggressive behavior of triple-negative breast carcinoma.
Billan S; Abdah-Bortnyak R; Stein ME; Kuten A
Isr Med Assoc J; 2009 Apr; 11(4):250. PubMed ID: 19603601
[No Abstract] [Full Text] [Related]
13. [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].
Illiger HJ
Strahlenther Onkol; 2002 Feb; 178(2):111-3. PubMed ID: 11942036
[No Abstract] [Full Text] [Related]
14. [A case of elderly locally-advanced breast cancer with skin ulcer responding to letrozole].
Sasaki Y; Okuyama M; Hibino M; Tenma K; Nakamura M
Gan To Kagaku Ryoho; 2012 Jun; 39(6):1005-8. PubMed ID: 22705703
[TBL] [Abstract][Full Text] [Related]
15. On the recovery of trastuzumab-related cardiac dysfunction.
Gillham CM; Chalmers AC; Plowman PN
Clin Oncol (R Coll Radiol); 2001; 13(2):146. PubMed ID: 11373881
[No Abstract] [Full Text] [Related]
16. Docetaxel induced Lyell's syndrome: a rare life threatening cause of dermatitis medicamentosas.
Arshad F; Bhat TS; Lone AR
J Cancer Res Ther; 2014; 10(3):742-4. PubMed ID: 25313773
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase II trial of letrozole plus anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancer.
Ibrahim NK; Yariz KO; Bondarenko I; Manikhas A; Semiglazov V; Alyasova A; Komisarenko V; Shparyk Y; Murray JL; Jones D; Senderovich S; Chau A; Erlandsson F; Acton G; Pegram M
Clin Cancer Res; 2011 Nov; 17(21):6822-30. PubMed ID: 21878535
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
19. Letrozole for advanced breast cancer.
Hoctin-Boes G; Yates R; Steinberg M
J Clin Oncol; 1998 Aug; 16(8):2892-3. PubMed ID: 9704745
[No Abstract] [Full Text] [Related]
20. Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen.
Mann BS; Johnson JR; Kelly R; Sridhara R; Williams G; Pazdur R
Clin Cancer Res; 2005 Aug; 11(16):5671-7. PubMed ID: 16115902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
